These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effects of cholestasis on membrane flow and surface polarity in hepatocytes. Stieger B; Landmann L J Hepatol; 1996; 24 Suppl 1():128-34. PubMed ID: 8926364 [No Abstract] [Full Text] [Related]
25. [Prolactin: control of its secretion and pharmacological interference]. Jacobelli A; Negro M; Poti C Clin Ter; 1980 Dec; 95(6):687-98. PubMed ID: 7011666 [No Abstract] [Full Text] [Related]
26. [Nuclear prolactin receptor manifestation in the rat hepatocytes and effect of prolactin]. Orlova AN; Smirnova OV; Turovetskiĭ VB; Smirnov AN Biull Eksp Biol Med; 1999 May; 127(5):579-82. PubMed ID: 10399588 [No Abstract] [Full Text] [Related]
27. Prolactin. Physiology, pharmacology and clinical findings. Flückiger E; del Pozo E; von Werder K Monogr Endocrinol; 1982; 23():1-224. PubMed ID: 7033768 [No Abstract] [Full Text] [Related]
28. Interactions between prolactin and immune processes. Di Carlo R; Meli R Acta Neurol (Napoli); 1991 Aug; 13(4):380-5. PubMed ID: 1781314 [No Abstract] [Full Text] [Related]
29. [Mechanisms of discrimation of the prolatin physiologic action on the liver at the receptor level of hepatocytes and cholangiocytes]. Smirnova OV; Bogorad RL Ross Fiziol Zh Im I M Sechenova; 2005 Feb; 91(2):184-94. PubMed ID: 15835542 [TBL] [Abstract][Full Text] [Related]
30. [Role of prolactin in experimental breast cancer. 1]. Nagasawa H Horumon To Rinsho; 1971 Aug; 19(8):625-9. PubMed ID: 4938502 [No Abstract] [Full Text] [Related] [Previous] [New Search]